UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER
kmUU300MXic
kmUU300MXic
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Presentations<br />
Clinical activity of anti-programmed death-1 (PD-1) agents in acral and<br />
mucosal melanoma.<br />
Authors*: Rodrigo Ramella Munhoz, Alexander Noor Shoushtari, Deborah Kuk, Patrick Alexander Ott,<br />
Douglas Buckner Johnson, Katy K. Tsai, Suthee Rapisuwon, Zeynep Eroglu, Ryan J. Sullivan,<br />
Jason John Luke, Tara C. Gangadhar, April K. Salama, Varina Clark, Clare Burias, Igor Puzanov,<br />
Michael B. Atkins, Alain Patrick Algazi, Antoni Ribas, Jedd D. Wolchok, Michael Andrew Postow<br />
Abstract #: 9516<br />
Presentation Date/Time: Saturday, June 4: 1:00 - 4:30 PM<br />
Location: Hall A, Poster Board #121<br />
Poster Session: Melanoma/Skin Cancers<br />
Citation: J Clin Oncol 34, 2016 (suppl; abstr 9516)<br />
__________________________________________________________________________<br />
Randomized phase II/III trial of active immunotherapy with OPT-822/<br />
OPT-821 in patients with metastatic breast cancer.<br />
Authors*: Chiun-Sheng Huang, Alice L Yu, Ling-Ming Tseng, Louis W. C. Chow, Ming-Feng Hou,<br />
Sara A. Hurvitz, Richard B. Schwab, Chi-Huey Wong, James L. Murray, Hsien-Kun Chang, Hong-Tai Chang,<br />
Shin-Cheh Chen, Sung-Bae Kim, Youe-Kong Shue, Hope S. Rugo<br />
Abstract #: 1003<br />
Presentation Date/Time: Saturday, June 4: 1:15 - 4:15 PM<br />
Location: Hall D2<br />
Session: Breast Cancer - Triple-Negative/Cytotoxics/Local Therapy<br />
Citation: J Clin Oncol 34, 2016 (suppl; abstr 1003)<br />
Rugo Research Interests: Dr. Rugo, Director of Breast Oncology & Clinical Trials Education, is PI on multiple<br />
clinical trials focusing on combining novel targeted therapeutics to improve the treatment of both early & late<br />
stage breast cancer (BC). She also works on studies to improve supportive care for early & late stage BC<br />
patients, including with <strong>UCSF</strong>’s Advanced Breast Cancer Program. Dr. Rugo has numerous collaborations with<br />
large academic medical centers & consortia in order to expand the novel therapies available to patients. She<br />
was the director of the 2016 ASCO Breast Cancer Education Committee meeting, is a member of the Alliance<br />
& is a founding member of the Breast Cancer Research Consortium where she co-leads the triple negative<br />
working group. She is on the novel agents committee for the neoadjuvant multi-center I SPY2 trial. At <strong>UCSF</strong>,<br />
Dr. Rugo runs the Breast Forum, a bimonthly educational session for breast cancer patients, families & friends<br />
from throughout the bay area.<br />
http://cancer.ucsf.edu/people/profiles/rugo_hope.3648<br />
*<strong>UCSF</strong> authors in bold<br />
36
Change language